8-119731990-C-CT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_003184.4(TAF2):c.3533dupA(p.Glu1179fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
TAF2
NM_003184.4 frameshift
NM_003184.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.32
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF2 | ENST00000378164.7 | c.3533dupA | p.Glu1179fs | frameshift_variant | 26/26 | 1 | NM_003184.4 | ENSP00000367406.2 | ||
TAF2 | ENST00000686879.1 | c.3689dupA | p.Glu1231fs | frameshift_variant | 27/27 | ENSP00000509206.1 | ||||
TAF2 | ENST00000685235.1 | c.3578dupA | p.Glu1194fs | frameshift_variant | 26/26 | ENSP00000510174.1 | ||||
TAF2 | ENST00000688645.1 | c.3422dupA | p.Glu1142fs | frameshift_variant | 25/25 | ENSP00000509978.1 | ||||
TAF2 | ENST00000523904.2 | c.3419dupA | p.Glu1141fs | frameshift_variant | 25/25 | 3 | ENSP00000430832.2 | |||
TAF2 | ENST00000690144 | c.*664dupA | 3_prime_UTR_variant | 26/26 | ENSP00000510548.1 | |||||
TAF2 | ENST00000685202.1 | n.*1058dupA | non_coding_transcript_exon_variant | 27/27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2925dupA | non_coding_transcript_exon_variant | 26/26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3405dupA | non_coding_transcript_exon_variant | 28/28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*5000dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3234dupA | non_coding_transcript_exon_variant | 24/24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3251dupA | non_coding_transcript_exon_variant | 27/27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3348dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2178dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2952dupA | non_coding_transcript_exon_variant | 23/23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3140dupA | non_coding_transcript_exon_variant | 26/26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2769dupA | non_coding_transcript_exon_variant | 26/26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1945dupA | non_coding_transcript_exon_variant | 26/26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3189dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3399dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3401dupA | non_coding_transcript_exon_variant | 28/28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2920dupA | non_coding_transcript_exon_variant | 25/25 | ENSP00000509603.1 | |||||
TAF2 | ENST00000685202.1 | n.*1058dupA | 3_prime_UTR_variant | 27/27 | ENSP00000509214.1 | |||||
TAF2 | ENST00000685503.1 | n.*2925dupA | 3_prime_UTR_variant | 26/26 | ENSP00000509198.1 | |||||
TAF2 | ENST00000685663.1 | n.*3405dupA | 3_prime_UTR_variant | 28/28 | ENSP00000508988.1 | |||||
TAF2 | ENST00000685684.1 | n.*5000dupA | 3_prime_UTR_variant | 25/25 | ENSP00000509441.1 | |||||
TAF2 | ENST00000685824.1 | n.*3234dupA | 3_prime_UTR_variant | 24/24 | ENSP00000510262.1 | |||||
TAF2 | ENST00000685876.1 | n.*3251dupA | 3_prime_UTR_variant | 27/27 | ENSP00000510493.1 | |||||
TAF2 | ENST00000685993.1 | n.*3348dupA | 3_prime_UTR_variant | 25/25 | ENSP00000510102.1 | |||||
TAF2 | ENST00000686098.1 | n.*2178dupA | 3_prime_UTR_variant | 25/25 | ENSP00000509102.1 | |||||
TAF2 | ENST00000688037.1 | n.*2952dupA | 3_prime_UTR_variant | 23/23 | ENSP00000510169.1 | |||||
TAF2 | ENST00000689919.1 | n.*3140dupA | 3_prime_UTR_variant | 26/26 | ENSP00000510768.1 | |||||
TAF2 | ENST00000690808.1 | n.*2769dupA | 3_prime_UTR_variant | 26/26 | ENSP00000509791.1 | |||||
TAF2 | ENST00000690922.1 | n.*1945dupA | 3_prime_UTR_variant | 26/26 | ENSP00000509498.1 | |||||
TAF2 | ENST00000691880.1 | n.*3189dupA | 3_prime_UTR_variant | 25/25 | ENSP00000508515.1 | |||||
TAF2 | ENST00000692518.1 | n.*3399dupA | 3_prime_UTR_variant | 25/25 | ENSP00000508959.1 | |||||
TAF2 | ENST00000692707.1 | n.*3401dupA | 3_prime_UTR_variant | 28/28 | ENSP00000509024.1 | |||||
TAF2 | ENST00000692916.1 | n.*2920dupA | 3_prime_UTR_variant | 25/25 | ENSP00000509603.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727242
GnomAD4 exome
AF:
AC:
1
AN:
1461882
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with TAF2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the TAF2 gene (p.Glu1179Glyfs*40). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 21 amino acid(s) of the TAF2 protein and extend the protein by 18 additional amino acid residues. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.